4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-23-000076
Chief Operating Officer sold 21,521 shares at $17.76 ($382,213)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jarrett Jennifer · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-22 | Sale : show line 1 in the form 10b5-1 | −21,521 | $17.76 | $382,213 | 258,878 | D |
| Open-market sales · 21,521 sh · avg $17.76 · $382,213 | ||||||
Loading xslF345X05/wk-form4_1703624687.xml…